All Stories

  1. Physiotherapy telerehabilitation activity and cost as part of the Australian government Medicare Benefits Scheme (MBS)
  2. Impact evaluation of the modified adverse inpatient medication event (AIME-Frail) model in hospitalised adults
  3. Evaluating the Effectiveness of Risk Categories for Prioritising Patients for Best Possible Medication History Completion at a Quaternary Hospital
  4. Remote patient monitoring outpatient telepharmacy services: A systematic review
  5. Pharmacist-Led Transition of Care Services in Patients with Cardiovascular Disease: A Systematic Scoping Review
  6. Telephone versus video consultations: A systematic review of consumer and provider preferences
  7. A post-discharge pharmacist clinic to reduce hospital readmissions: a retrospective cohort study
  8. Smoking cessation support preferences among people released from smoke-free prisons in Queensland, Australia
  9. ‘Don't Assume, Ask’: A Collaboration With Consumers, Interpreters, Clinicians and Health Service Staff to Increase Video Telehealth in Culturally and Linguistically Diverse Groups
  10. Telehealth-facilitated palliative care enables more people to die at home: An analysis of clinical outcomes and service activity data
  11. Trust and confidence in telehealth-delivered services: a nation-wide cross-sectional study
  12. A cost-consequence analysis of the Queensland specialist palliative rural telehealth (SPaRTa) service
  13. Utilizing technology for diet and exercise change in complex chronic conditions across diverse environments (U-DECIDE): feasibility randomised controlled trial
  14. The adverse inpatient medication event and frailty (AIME-frail) risk prediction model
  15. A systematic review of synchronous telepharmacy service models for adult outpatients with cancer
  16. Systematic review and meta-analysis of text messaging interventions to support tobacco cessation
  17. Economic evaluations of telepharmacy services in non-cancer settings: A systematic review
  18. It Was Like Going to a Battlefield: Lived Experience of Frontline Nurses Supporting Two Hospitals in Wuhan During the COVID-19 Pandemic
  19. Patients’ acceptability of self-selected digital health services to support diet and exercise among people with complex chronic conditions: Mixed methods study
  20. General practitioner preferences for telehealth consultations in Australia: a pilot survey and discrete choice experiment
  21. Cost-effectiveness of remote patient monitoring for First Nations peoples living with diabetes in regional Australia
  22. Development and validation of the Digital Health Acceptability Questionnaire
  23. Does the requirement for an interpreter impact experience with telehealth modalities, acceptability and trust in telehealth? Results from a national survey including people requiring interpreter services
  24. A cross-sectional study exploring equity of access to telehealth in culturally and linguistically diverse communities in a major health service
  25. Digital health literacy to enhance workforce skills and clinical effectiveness: A response to ‘Digital health literacy: Helpful today, dependency tomorrow? Contingency planning in a digital age’
  26. Pharmacist vs machine: Pharmacy services in the age of large language models
  27. Gestational diabetes mellitus care re‐imagined – A cost‐minimisation analysis: Cost savings from a tertiary hospital, using a novel, digital‐based gestational diabetes management model
  28. Introducing a Digital Occupational Violence Risk Assessment Tool Into an Emergency Department: A Pilot Implementation Study
  29. Artificial intelligence: Augmenting telehealth with large language models
  30. The roles and perspectives of an informatics pharmacist practicing in the Australian healthcare setting: a qualitative study
  31. Cost-effectiveness of telehealth-delivered nutrition interventions: a systematic review of randomized controlled trials
  32. How do consumers prefer their care delivered: In-person, telephone or videoconference?
  33. Inter-rater reliability of the occupational violence risk assessment tool for emergency departments
  34. Assessing the Effect of an Inpatient Smoking Cessation Brief Intervention Tool on Long-Term Smoking Cessation Rates and Patient Interest for Nicotine Replacement Therapy: A Retrospective Analysis
  35. Medicare reimbursed telehealth exercise physiology services were underutilised through the coronavirus (COVID-19) pandemic: an ecological study
  36. An evaluation of telephone versus videoconference consults for pre-treatment medication history taking by cancer pharmacists
  37. Costs to the Medicare Benefits Schedule for general practitioner consultations: A time-series analysis
  38. Dementia ECHO: Evaluation of a telementoring programme to increase dementia knowledge and skills in First Nations-led health services
  39. Health literacy, dementia knowledge and perceived utility of digital health modalities among future health professionals
  40. Three-dimensional (3D) printing for post-traumatic orbital reconstruction, a systematic review and meta-analysis
  41. Exploring factors of uneven use of telehealth among outpatient pharmacy clinics during COVID-19: A multi-method study
  42. The impact of telehealth policy changes on general practitioner consultation activity in Australia: a time-series analysis
  43. Pharmacists reducing medication risk in medical outpatient clinics: a retrospective study of 18 clinics
  44. Increase in telemental health services on the Medicare Benefits Schedule after the start of the coronavirus pandemic: data from 2019 to 2021
  45. Telehealth sustainability after COVID-19 – can you see me by video?
  46. How have temporary Medicare telehealth item numbers impacted the use of dietetics services in primary care settings?
  47. Are Telehealth-Delivered Nutrition Care Interventions Cost-Effective for Managing Chronic Diseases? A Systematic Review of All Payer Perspectives
  48. Economic Evaluations of Remote Patient Monitoring for Chronic Disease: A Systematic Review
  49. Implications of increased telehealth use on organisations providing mental health services during COVID-19
  50. Infusion reaction incidence after switching all patients to an infliximab biosimilar in an Australian hospital
  51. Benefits, challenges and contributors to the introduction of new hospital-based outpatient clinic pharmacist positions
  52. Quantifying the Societal Benefits From Telehealth: Productivity and Reduced Travel
  53. Validity and reliability of the novel three‐item occupational violence patient risk assessment tool
  54. Associations between mental illness and non-medical use of prescription opioids among a sample of people who use drugs in Australia and New Zealand
  55. Mental illnesses as a potential risk factor for non‐medical use of prescription opioids: a narrative review
  56. Is the use of ranitidine required as a pre‐medication to prevent hypersensitivity reactions to paclitaxel?
  57. Smoking status on subsequent readmission to hospital: The impact of inpatient brief interventions for smokers
  58. The right time and place: the need for seven‐day pharmacist service models
  59. GP perceptions of telehealth services in Australia: a qualitative study
  60. Changing from telephone to videoconference for pre-treatment pharmacist consults in cancer services: Impacts to funding and time efficiency
  61. Enhancing a community palliative care service with telehealth leads to efficiency gains and improves job satisfaction
  62. Optimising specialist geriatric medicine services by telehealth
  63. Specialist consultation activity and costs in Australia: Before and after the introduction of COVID-19 telehealth funding
  64. Economic evaluations of videoconference and telephone consultations in primary care: A systematic review
  65. Infliximab switching from reference product to biosimilar: a review of evidence regarding the clinical efficacy, safety profile and immunogenicity
  66. Text automation tool to improve pharmacist productivity and work capacity in a digital hospital: a pilot study
  67. Consumer Preference and Willingness to Pay for Direct-to-Consumer Mobile Teledermoscopy Services in Australia
  68. Factors influencing the effectiveness of remote patient monitoring interventions: a realist review
  69. An evaluation of pharmacist activity in hospital outpatient clinics
  70. Why telehealth does not always save money for the health system
  71. Does the Choice Between a Telehealth and an In-Person Appointment Change Patient Attendance?
  72. An overview of the effect of telehealth on mortality: A systematic review of meta-analyses
  73. The clinical effectiveness of telehealth: A systematic review of meta-analyses from 2010 to 2019
  74. Patient preferences for specialist outpatient video consultations: A discrete choice experiment
  75. Addressing concerns and adapting psychological techniques for videoconsultations: a practical guide
  76. What can we do about occupational violence in emergency departments? A survey of emergency staff
  77. Does remote patient monitoring reduce acute care use? A systematic review
  78. Exploring paramedics’ intention to use a specialist palliative care telehealth service
  79. Paying for Telemedicine After the Pandemic
  80. A Systematic Review and Meta-Analysis of Change in Health-Related Quality of Life for Interactive Telehealth Interventions for Patients With Asthma
  81. A retrospective review examining intravenous iron infusion dosing methods
  82. The pharmacist informatician: providing an innovative model of care during the COVID-19 crisis
  83. Skin Doctor Consultations Using Mobile Teledermoscopy: Exploring Virtual Care Business Models
  84. Determining if Telehealth Can Reduce Health System Costs: Scoping Review
  85. An audit of the quantity of immediate release oxycodone 5 mg tablets prescribed for discharge: an area for improved opioid stewardship?
  86. Economic benefits of pharmacy technicians practicing at advanced scope: A systematic review
  87. Building on the momentum: Sustaining telehealth beyond COVID-19
  88. Long-term effects of childhood speech and language disorders: A scoping review
  89. Evaluating the utility of a Smoking Cessation Clinical Pathway tool to promote nicotine prescribing and use among inpatients of a tertiary hospital in Brisbane, Australia
  90. Nicotine vaping products as a harm reduction tool among smokers: Review of evidence and implications for pharmacy practice
  91. Transit Care Hub pharmacist: improving patient flow within the hospital
  92. A Systematic Review of Pediatric Telediabetes Service Models
  93. Economic Advantages of Telehealth and Virtual Health Practitioners: Return on Investment Analysis
  94. Use of Reimbursed Psychology Videoconference Services in Australia: An Investigation Using Administrative Data
  95. Commentary on Conigrave et al . (2020): Meta‐analysis of drinking patterns in Aboriginal and Torres Strait Islander populations highlights policy and research opportunities
  96. Current Economic Evidence for Teledermoscopy
  97. The Role of Telehealth in Reducing the Mental Health Burden from COVID-19
  98. Telehealth for global emergencies: Implications for coronavirus disease 2019 (COVID-19)
  99. Integrating a pharmacist into the perioperative setting
  100. Is Teledermoscopy Ready to Replace Face-to-Face Examinations for the Early Detection of Skin Cancer? Consumer Views, Technology Acceptance, and Satisfaction with Care
  101. Accuracy checking of dispensed medications by a pharmacy technician: a hospital case study
  102. Telehealth uptake in general practice as a result of the coronavirus (COVID-19) pandemic
  103. The breakeven point for implementing telehealth
  104. A cost-consequence analysis comparing patient travel, outreach, and telehealth clinic models for a specialist diabetes service to Indigenous people in Queensland
  105. Immersive Virtual Reality in Health Care: Systematic Review of Technology and Disease States
  106. A meta-analysis of pharmacists and pharmacy technicians’ accuracy checking proficiency
  107. A Commentary on the Dose–Response Relationship of Alcohol and Injury: Effects of Country‐Level Drinking Patterns and Alcohol Policies
  108. Pharmacy-led ward-based education reduces pharmaceutical waste and saves money
  109. Direct-to-consumer mobile teledermoscopy for skin cancer screening: Preliminary results demonstrating willingness-to-pay in Australia
  110. What do Australian dermatologists expect to be paid for store-and-forward teledermoscopy? A preliminary investigation
  111. Cost-effectiveness of Skin Cancer Referral and Consultation Using Teledermoscopy in Australia
  112. Economic evaluation strategies in telehealth: Obtaining a more holistic valuation of telehealth interventions
  113. Inpatient smoking cessation - turn to your clinical pharmacist
  114. Knowledge and attitudes of final year pharmacy students toward opioid substitution therapy
  115. Economics of teledermatology